The Thermo Fisher Scientific Accula system is a rapid diagnostic point of care platform that provides simple, accurate sample-to-answer rapid PCR. Using a palm-sized Accula Dock in a CLIA waived environment, the Accula rapid PCR Tests provides reliable, qualitative PCR results in 30 minutes.

NOTE: Testing for the Accula SARS-CoV-2 Test is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet requirements to perform high, moderate, or waived complexity tests. The Accula SARS-CoV-2 Test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

A CLIA Certificate of waiver number is required prior to order fulfillment.

*
*
*
*
*
*
*
*
 Flu A/B
 RSV
 SARS-CoV-2
 Strep A
 Other
 
 Yes
 No
 
 
 Yes
 No
 
 
 To the best of my knowledge, the organization I represent has a CLIA Certificate of Waiver or plans on getting the certification in the near future.
 Please confirm you would like to receive marketing and promotional email messages about products and services from Thermo Fisher Scientific and its brands in accordance with our privacy statement.
By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Thermo Fisher Scientific Privacy Policy.